| 000 | 01550 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514062536.0 | ||
| 264 | 0 | _c20030410 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(02)80014-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGore, M E | |
| 245 | 0 | 0 |
_aResults of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cDec 2002 |
||
| 300 |
_aS7-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematologic Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAtkinson, R J | |
| 700 | 1 | _aThomas, H | |
| 700 | 1 | _aCure, H | |
| 700 | 1 | _aRischin, D | |
| 700 | 1 | _aBeale, P | |
| 700 | 1 | _aBougnoux, P | |
| 700 | 1 | _aDirix, L | |
| 700 | 1 | _aSmit, W M | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 38 Suppl 8 _gp. S7-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(02)80014-4 _zAvailable from publisher's website |
| 999 |
_c12440004 _d12440004 |
||